Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Nash

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 11, 2005
Subcellular redistribution of the synapse-associated proteins PSD-95 and SAP97 in animal models of Parkinson's disease and L-DOPA-induced dyskinesiaJ E Nash, T H Johnston, G L Collingridge, et al.
Neurotoxicity Research|April 25, 2012
Evidence for synergism between cell death mechanisms in a cellular model of neurodegeneration in Parkinson's diseaseC J Yong-Kee, R Warre, P P Monnier, et al.
Experimental Neurology|July 13, 2004
The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP-lesioned marmoset model of Parkinson's diseaseJ E Nash, P Ravenscroft, S McGuire, et al.
Investigative Radiology|May 1, 1991
Percutaneous gallstone lithotripsy. Results in acute and chronic swine modelsK R Kensey, M Michels, C Abrahams, et al.
Chest|October 1, 1990
Mechanical disruption of pulmonary emboli in dogs with a flexible rotating-tip catheter (Kensey catheter)P D Stein, H N Sabbah, M A Basha, et al.
Radiology|March 1, 1991
Percutaneous rotational contact biliary lithotripsy: initial clinical results with the Kensey Nash lithotriteF J Miller, S C Rose, K N Buchi, et al.
The British Journal of Nutrition|April 1, 1994
The effect of acute and chronic administration of the beta-agonist, cimaterol, on protein synthesis in ovine skin and muscleJ E Nash, H J Rocha, V Buchan, et al.
Journal of Genetic Counseling|July 5, 2015
BRCA1 Testing: Genetic Counseling Protocol Development and Counseling IssuesB J Baty, V L Venne, J McDonald, et al.
Experimental Neurology|August 31, 2000
Antiparkinsonian actions of ifenprodil in the MPTP-lesioned marmoset model of Parkinson's diseaseJ E Nash, S H Fox, B Henry, et al.
Journal of the National Cancer Institute|July 3, 1996
A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testingJ R Botkin, R T Croyle, K R Smith, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 11, 2005
Subcellular redistribution of the synapse-associated proteins PSD-95 and SAP97 in animal models of Parkinson's disease and L-DOPA-induced dyskinesiaJ E Nash, T H Johnston, G L Collingridge, et al.
Neurotoxicity Research|April 25, 2012
Evidence for synergism between cell death mechanisms in a cellular model of neurodegeneration in Parkinson's diseaseC J Yong-Kee, R Warre, P P Monnier, et al.
Experimental Neurology|July 13, 2004
The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP-lesioned marmoset model of Parkinson's diseaseJ E Nash, P Ravenscroft, S McGuire, et al.
Investigative Radiology|May 1, 1991
Percutaneous gallstone lithotripsy. Results in acute and chronic swine modelsK R Kensey, M Michels, C Abrahams, et al.
Chest|October 1, 1990
Mechanical disruption of pulmonary emboli in dogs with a flexible rotating-tip catheter (Kensey catheter)P D Stein, H N Sabbah, M A Basha, et al.
Radiology|March 1, 1991
Percutaneous rotational contact biliary lithotripsy: initial clinical results with the Kensey Nash lithotriteF J Miller, S C Rose, K N Buchi, et al.
The British Journal of Nutrition|April 1, 1994
The effect of acute and chronic administration of the beta-agonist, cimaterol, on protein synthesis in ovine skin and muscleJ E Nash, H J Rocha, V Buchan, et al.
Journal of Genetic Counseling|July 5, 2015
BRCA1 Testing: Genetic Counseling Protocol Development and Counseling IssuesB J Baty, V L Venne, J McDonald, et al.
Experimental Neurology|August 31, 2000
Antiparkinsonian actions of ifenprodil in the MPTP-lesioned marmoset model of Parkinson's diseaseJ E Nash, S H Fox, B Henry, et al.
Journal of the National Cancer Institute|July 3, 1996
A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testingJ R Botkin, R T Croyle, K R Smith, et al.
Pageof 4